tetano
Editor, Senior Moderator
J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16578. [Epub ahead of print]
Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus.
Balestri R[SUP]1[/SUP], Rech G[SUP]1[/SUP], Girardelli CR[SUP]1[/SUP].
Author information
Abstract
we read with great interest the article entitled "Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?" published by Di Altobrando A. et al. in the JEADV. This is the first report of COronaVIrus DIsease 2019 (COVID-19) in a patient affected by autoimmune blistering disease (ABD) during immunosuppressive treatment (i.e. azathioprine). The authors conclude that it is crucial to learn of more cases of ABD patients under immunosuppressive treatment who have developed COVID-19, in order to better quantify the risk of infection under immunosuppressive therapy.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; SARS-CoV-2; blistering disorders; bullous disorders; immunosuppressive therapy; mycophenolate mofetil
PMID:32359182DOI:10.1111/jdv.16578
Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus.
Balestri R[SUP]1[/SUP], Rech G[SUP]1[/SUP], Girardelli CR[SUP]1[/SUP].
Author information
Abstract
we read with great interest the article entitled "Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?" published by Di Altobrando A. et al. in the JEADV. This is the first report of COronaVIrus DIsease 2019 (COVID-19) in a patient affected by autoimmune blistering disease (ABD) during immunosuppressive treatment (i.e. azathioprine). The authors conclude that it is crucial to learn of more cases of ABD patients under immunosuppressive treatment who have developed COVID-19, in order to better quantify the risk of infection under immunosuppressive therapy.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; SARS-CoV-2; blistering disorders; bullous disorders; immunosuppressive therapy; mycophenolate mofetil
PMID:32359182DOI:10.1111/jdv.16578